INTRODUCTION
Anemia is identified as the most common complication seen in patients with HIV infection because it has been documented that up to 95% of HIV/AIDS patients are anemic' Sullivan et al} also reported that up to'30% of asymptomatic HIV patients have anemia while up to 90% of them that have AIDS also have anemia. The most common anemias encountered in patients with HIV/AIDS is iron deficiency anemia and anemia of chronic disease. Iron deficiency (ID) is one of the major underlying nutritional factors of HIV anemia. It is worthy of note that it is difficult to quantify the contribution of ID to the anemia of HIV infection because in inflammatory condition of HIV disease, the proinfiammatory cytokines induce an anemia of inflammation (anemia of chronic disease) and alter biochemical indicators of iron status that are commonly used to diagnose ID.Â lthough the reasons are not fully understood, anemia of chronic disease occurs widely among people living with HIV/AIDS.^ Some researchers associate the anemia with HIV-disease progression and an increased risk of death,^ even independent of CD4 count and viral load.'' Apart from elevated proinflammatory cytokines, other risk factors for HIV-related anemia of chronic disease have been identified, including clinical AIDS, CD4+ cell counts <200 cells/mL, high plasma viral load, female sex, African American ethnicity, and zidovudine use.N utrition is also an important factor in the course of HIV infection and is generally accepted as a major determinant of immune functioning. Nutritional factors, although not the most important etiological determinants may change immune function to facilitate disease progression, influence viral expression, and play a significant role in disease processes and related morbidity and mortality.'' Among all the nutrients, iron stands out as having a partictilarly crucial role in mediating host-pathogen interactions. Iron also plays a role in immune function and cognitive status and many other reactions including the synthesis of DNA, collagen, and bile acids.''
The paucity of studies on iron status in anemia of chronic disease among HIV-infected persons in subSaharan Africa is an important research gap, as there is evidence that decreased iron status,* as well as elevated storage iron*'' in anemia of chronic disease may lead to adverse HIV-related outcomes. The potential risks of altered iron status in anemia of chronic disease are of special relevance for treatment programs recommending supplemental iron for patients with HIV infection."" To expand the knowledge on indicators of iron status in anemia of chronic disease with its relation to CD4 count in Makurdi metropolis, we conducted a study in HIV-infected persons attending Eederal Medical Center, Makurdi in Benue state, North-Central Nigeria.
MATERIALS AND METHOD

Subjects
A total of 312 subjects, comprising of 207 confirmed HIV positive patients attending Federal Medical Center, Makurdi, Benue state, Nigeria and 105 confirmed HIV negative as controls drawn from volunteers living within Makurdi metropolis were recruited in the study. The selection of the volunteers who were apparently healthy individuals was based on the following criteria: age range between 25-60 years, no history of drug usage (including vitamins/iron, antibiotics), no recent history of blood loss, and must not have received any blood transfusion in the previous 12 months. Additional criteria for females included not being pregnant, and not lactating or menstruating at the time of blood collection. Ethical approval was sought for and obtained from the ethical standard committee of the Federal Medical Centre, Makurdi, and informed consent was obtained from the subjects before samples were collected.
Sample Collection
A total of 5ml non-hemolysed blood was drawn from each confirmed HIV positive and negative volunteers in the morning after an overnight fast of between 9pm and 8am. While 2ml was transferred into a clean, screwcapped glass tube without anticoagulant and allowed to stand at room temperature until separation of the serum was started by centrifugation speed of 3000 rev/min for 5 minutes. The separated sera were kept at below 20°C until analyses were done. Analyses conducted on the sera were the determination of serum iron and unsaturated iron binding capacity, and calculation of total iron-binding capacity and iron saturation. The remaining 3ml of blood was transferred into an EDTA anticoagulated bottles for immediate analyses of Indices of anemia.
Sample Analysis
The analyses were done at the Laboratory services building, Hematology and Chemical Pathology Sections, at Federal Medical Center, Makurdi. Before the analysis, the separated frozen sera were placed at room temperature to allow thawing, and were then mixed.
HTV Screening and Confirmatory Tests
HIV rapid screening was carried out using Uni-Gold HIVl/2 and Determine HIVl/2 assay kits (Abbott, Germany). While the confirmatory tests were conducted using Western Blot kits (Immunetics, Boston USA)
CD4 Count Analysis
Enumeration of CD4 lymphocyte count was performed using SL Cyflow machine (Artec, Germany).
Indices of Anemia
Indices of anemia including Hb, PCV, RBC, MCV, MCH, MCHC and RDWCV was carried out using the SYSMEX KX-21N hematology analyzer method (Kobe, Japan).
Measurement of Serum Lron and Unsaturated Lron Binding Capacity (UIBC)
Serum Iron concentration and UIBC was measured by the Forrozine method" and the assay was carried out using the Iron/TIBC reagent set (TECO Diagnostics, Anaheim, Germany) by colometric method. Before running the assay, the analyzer was calibrated by iron standard (500ng/dl) included in each kit. To assess the accuracy of the analyzer, Precinorm U and Precipath U controls were run with the assay in addition to Precinorm UPX control, which was used to assess precision.
Total Lron Binding Capacity (TLBC) and Lron Saturation (LS) Fraction
The TIBC and IS" were calculated according to the following formulae: were the major contributors of anemia especially in the males while anemia in the females was ; largely contributed by hemoglobin concentration!. The prevalence of HIV/AIDS among males and females as well as at different age groups is shown at Figure 1 and II. The female group showed higher prevalence (77%) compared with male (23%). While within the different age groups the highest prevalence was found within the 25-34 age groups (54%).
DISCUSSION
The moderate reduction in Hb concentration; PCV, and the total RBC count of test subjects is statistically significant (P<0.05) compared with the controls (Table  1) . This general reduction suggests anemia. In this study Hb concentration was chosen to define the anemic status of the test subjects since the degree or severity of the anemia is directly proportional to the concentration of the haemoglobin as suggested by Abram et al.^Â nemia was defined as Hb <11.O g/dl, according to the WHO-recommended cutoff of 12.0 g/dl minus a 10 g/L adjustment to account for lower Hb reported in blacks.'^ It is important to note that in the presence of Figure 1 . Prevalence of HIV/AIDS among male and female groups anemia, the iron status of this group of subjects lie within the reference range albeit they (except TIBC) showed statistical significance (p<0.05) to controls. This is not consistent with studies by Fuchs et al.^^ and Gordeuk et al.,'' which showed relatively lower values of iron status in HIV patients. These higher values of iron status may be a reflection of adequate iron stores, probably due to high levels of meat consumption among Makurdi residents. The significant influence of meat intake on iron stores among adults has been reported and serum iron levels decrease once body iron stores are depleted, and increase with iron overload.'
In an attempt to further evaluate the indicators of iron status in anemia of chronic disease, we stratified the test subjects on the basis of CD4 value (Table 2) . Patients are adjudged to have AIDS with the CD4 count <200 cells^/L. In this study therefore, 55.2% of patients with CD <200 cells/mm^ are anemic with iron status which did not differ significantly (p>0.05) from those patients with CD4 >200 celIs/mm^ of which 32.5% are anemic. However, close observation revealed that the indicators of iron status and anemia were relatively lower than that of the Table 1 above, which further revealed the impact of AIDS.
Among the indices of anemia, Hb, PCV, and MCH showed signiflcant difference (p<0.05) compared with the patients with CD4 >200cells/mm^ (Table 2 ). An MCV value below 81 fL indicates that the erythrocytes are microcytic (small), while a MCH below 27pg indicates that the erythrocytes are hypochromic (pale). A microcytic, hypochromic anemia occurs when body stores are depleted and the iron deficiency is severe, but both the MCV and MCH remain normal in early iron deflciency. In contrast to iron deflciency anemia, the anemia of chronic disease is usually, but not always, characterized by a normocytic, hypochromic blood picture, which could explain the relatively high percentage of especially HIV-infected patients with CD4 <200cells/mm'. Furthermore, serum iron levels and transferrin saturation are low in chronic disease,' as was found in a low percentage of patients included in this study. The high levels of meat consumption among Makurdi residents have positively improved the iron status and anemia impacted by the disease similar to the report by Walsh et al '''
The prevalence of anemia described in this study ( We recommended that complete haemogram and serum ferritin of HIV/AIDS patients be investigated for differential diagnosis of anemia and effective management of their health conditions.
